Medicine: Fully Funded MRC PhD at Swansea University: Automated High Content Imaging
- Full cost of UK/EU tuition fees, plus a stipend
- 31 May 2019
Medicine: Fully Funded MRC PhD Scholarship: Automated High Content Imaging for Carcinogenicity Testing In Vitro
This scholarship is funded by the MRC, in conjunction with AstraZeneca.
Start date: October 2019
**Supervisor: **Professor Gareth Jenkins, Institute of Life Science, Swansea University
The assessment of DNA damage (genotoxicity) potential is a regulatory requirement for all new products to ensure that human exposure to genotoxins is minimised. As DNA damage drives carcinogenesis, this assessment is vital to prevent human cancer rates rising. Replacing animal tests for carcinogens with cell based (in vitro) approaches is also a major consideration.
This PhD will integrate the in vitro assessment of DNA damage potential with the assessment of perturbations to several cancer hallmarks to develop a holistic testing platform for assessing carcinogenic potential. This novel testing platform will be further validated at Swansea University and compared to a similar robotic system under development at Astra Zeneca laboratories (Cambridge).
Candidates should have a first degree in a biological sciences discipline with excellent experience of cell culture techniques.
We would normally expect the academic and English Language requirements (IELTS 6.5 or equivalent) to be met by point of application. For details on the University’s English Language entry requirements, please visit – http://www.swansea.ac.uk/admissions/english-language-requirements/
Please see the conditions of research council training grants for residence requirements.
This scholarship covers the full cost of UK/EU tuition fees and an annual stipend of £15,009 for four years.
Please visit our website for more information.
Sign Up for Scholarship Updates
Get an email every week that 10.000's of students use to get the latest scholarships.